XML 70 R59.htm IDEA: XBRL DOCUMENT v3.10.0.1
Revenue recognition - Cash Flow Impacts (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Apr. 08, 2018
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Cash flows from operating activities          
Net loss   $ (9,520) $ (17,475) $ (28,782) $ (46,532)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization       12,243 1,448
Change in valuation of warrant liability       0 3
Non-cash interest expense       3,644 3,274
Gain (Loss) on Disposition of Assets       0 47
Amortization of premiums and accretion of discounts on investments, net       (230) 365
Amortization of debt issuance costs       256 185
Share-based compensation expense       15,831 16,914
Deferred Income Tax Expense (Benefit)       0  
Unrealized foreign currency transaction (gains) losses, net       (764) 1,648
Changes in operating assets and liabilities:          
Inventory       (3,393) (2,806)
Prepaid expenses and other current assets       254 (416)
Trade receivables, net       (20,429) (6,762)
Deposits and other assets       (419) (463)
Accounts payable and accrued expenses       2,225 12,452
Other liabilities       485 457
Deferred revenue       3,204 4,604
Net cash used in operating activities       (15,875) (15,582)
Cash flows from investing activities          
Purchases of fixed assets       (1,187) (579)
Purchases of marketable securities       (28,656) (19,467)
Sale and redemption of marketable securities       35,939 144,357
Acquisition, including transaction costs       0 (76,424)
Net cash provided by investing activities       6,096 47,887
Cash flows from financing activities          
Proceeds from exercise of options       3,592 535
Net proceeds from public offerings $ 117,900     117,874 0
Net cash provided by financing activities       122,765 40,660
Effect of exchange rate changes on cash       (990) 1,725
Net increase in cash and cash equivalents       111,996 74,690
Cash and cash equivalents, beginning of period       111,792 58,321
Cash and cash equivalents, end of period   223,788 $ 133,011 223,788 133,011
Proceeds from shares issued under employee stock purchase plan       1,299 557
Debt issuance costs       0 (432)
Proceeds from issuance of secured term loan       0 $ 40,000
Adjustments | ASU 2014-09          
Cash flows from operating activities          
Net loss   591   (158)  
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization       0  
Change in valuation of warrant liability       0  
Non-cash interest expense       0  
Gain (Loss) on Disposition of Assets       0  
Amortization of premiums and accretion of discounts on investments, net       0  
Amortization of debt issuance costs       0  
Share-based compensation expense       0  
Deferred Income Tax Expense (Benefit)       0  
Unrealized foreign currency transaction (gains) losses, net       0  
Changes in operating assets and liabilities:          
Inventory       (67)  
Prepaid expenses and other current assets       0  
Trade receivables, net       0  
Deposits and other assets       0  
Accounts payable and accrued expenses       (649)  
Other liabilities       0  
Deferred revenue       874  
Net cash used in operating activities       0  
Cash flows from investing activities          
Purchases of fixed assets       0  
Purchases of marketable securities       0  
Sale and redemption of marketable securities       0  
Acquisition, including transaction costs       0  
Net cash provided by investing activities       0  
Cash flows from financing activities          
Proceeds from exercise of options       0  
Net proceeds from public offerings       0  
Net cash provided by financing activities       0  
Effect of exchange rate changes on cash       0  
Net increase in cash and cash equivalents       0  
Cash and cash equivalents, beginning of period       0  
Cash and cash equivalents, end of period   0   0  
Proceeds from shares issued under employee stock purchase plan       0  
Debt issuance costs       0  
Proceeds from issuance of secured term loan       0  
Balances without adoption of Topic 606          
Cash flows from operating activities          
Net loss   (8,929)   (28,940)  
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization       12,243  
Change in valuation of warrant liability       0  
Non-cash interest expense       3,644  
Gain (Loss) on Disposition of Assets       0  
Amortization of premiums and accretion of discounts on investments, net       (230)  
Amortization of debt issuance costs       256  
Share-based compensation expense       15,831  
Deferred Income Tax Expense (Benefit)       0  
Unrealized foreign currency transaction (gains) losses, net       (764)  
Changes in operating assets and liabilities:          
Inventory       (3,460)  
Prepaid expenses and other current assets       254  
Trade receivables, net       (20,429)  
Deposits and other assets       (419)  
Accounts payable and accrued expenses       1,576  
Other liabilities       485  
Deferred revenue       4,078  
Net cash used in operating activities       (15,875)  
Cash flows from investing activities          
Purchases of fixed assets       (1,187)  
Purchases of marketable securities       (28,656)  
Sale and redemption of marketable securities       35,939  
Acquisition, including transaction costs       0  
Net cash provided by investing activities       6,096  
Cash flows from financing activities          
Proceeds from exercise of options       3,592  
Net proceeds from public offerings       117,874  
Net cash provided by financing activities       122,765  
Effect of exchange rate changes on cash       (990)  
Net increase in cash and cash equivalents       111,996  
Cash and cash equivalents, beginning of period       111,792  
Cash and cash equivalents, end of period   $ 223,788   223,788  
Proceeds from shares issued under employee stock purchase plan       1,299  
Debt issuance costs       0  
Proceeds from issuance of secured term loan       $ 0